ArticleCancer medicine2024

Several factors that predict the outcome of large B-cell lymphoma patients who relapse/progress after chimeric antigen receptor (CAR) T-cell therapy can be identified before cell administration.

Alice Sýkorová et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.